| |
| |
|
| Insider
Information: |
Lebkowski Jane |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
671,145 |
|
|
Indirect Shares
|
21,177 |
|
|
| Direct
Value |
$2,250,630 |
|
|
|
Indirect Value
|
$80,261 |
|
|
| Total
Shares |
692,322 |
|
|
| Total
Value |
$2,330,891 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Geron Corporation |
GERN |
SVP, Chief Scientific ... |
2011-06-14 |
568,154 |
2010-01-14 |
21,177 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
|
2017-06-05 |
102,991 |
2014-08-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AST |
Asterias Biotherapeutics ... |
Chief Scientific Officer |
• • – |
2017-06-05 |
4 |
D |
$3.20 |
$22,448 |
D/D |
(7,015) |
102,991 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• • – |
2017-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
110,006 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• • – |
2017-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17,670 |
35,006 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• • – |
2017-01-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,537) |
17,336 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• • – |
2016-10-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,537) |
13,121 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• – – |
2016-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
27,007 |
27,007 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• – – |
2015-09-15 |
4 |
AS |
$6.00 |
$29,472 |
D/D |
(4,912) |
476 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• – – |
2015-06-30 |
4 |
D |
$4.60 |
$13,082 |
D/D |
(2,844) |
5,388 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
Pres., Research & Development |
• – – |
2014-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
476 |
476 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, Chief Scientific Officer |
• – – |
2011-06-14 |
4 |
S |
$4.28 |
$108,121 |
D/D |
(25,262) |
568,154 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, Chief Scientific Officer |
• – – |
2011-05-24 |
4 |
S |
$4.47 |
$13,298 |
D/D |
(2,975) |
593,416 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, Chief Scientific Officer |
• – – |
2011-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
99,500 |
596,391 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2010-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
496,891 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2010-06-02 |
4 |
S |
$5.43 |
$57,650 |
D/D |
(10,617) |
196,891 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2010-05-24 |
4 |
S |
$5.11 |
$11,937 |
D/D |
(2,336) |
207,508 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2010-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
209,844 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2010-01-14 |
4 |
A |
$6.22 |
$21,994 |
I/I |
3,536 |
21,177 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
184,844 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2009-05-29 |
4 |
S |
$6.35 |
$14,459 |
D/D |
(2,277) |
119,844 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2009-05-26 |
4 |
S |
$6.75 |
$95,121 |
D/D |
(14,092) |
122,121 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2009-01-23 |
4 |
A |
$4.82 |
$19,029 |
I/I |
3,948 |
17,641 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2009-01-05 |
4 |
S |
$4.90 |
$43,419 |
D/D |
(8,861) |
149,906 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2008-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
158,767 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2008-05-23 |
4 |
D |
$3.92 |
$54,300 |
D/D |
(13,852) |
133,767 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2008-01-04 |
4 |
S |
$5.34 |
$47,585 |
D/D |
(8,911) |
147,619 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
